This invention provides a method for preparing a composite solution of
sodium hyaluronate and recombinant type III humanized collagen. The invention utilizes artificial screening and design to obtain recombinant type III humanized collagen COL3A1-QS-1, which is highly efficient in
secretion and expression in
Pichia pastoris. Compared with animal-derived collagen, it has advantages such as uniform molecular weight, high purity, no risk of
viral transmission, low rejection reaction, and high bioactivity.
Sodium hyaluronate absorbs water and swells into a gel, physically filling
tissue volume loss and thus achieving the effect of filling wrinkles and
smoothing fine lines. Recombinant type III humanized collagen provides a
scaffold and favorable microenvironment for cells, promoting
cell adhesion, proliferation, growth, migration, and support for cells and tissues. The composite solution of
sodium hyaluronate and recombinant type III humanized collagen prepared from these two components stimulates collagen production by improving the local internal environment, thereby improving superficial wrinkles.